Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 3
2016 3
2017 5
2018 3
2019 5
2020 4
2021 5
2022 7
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.
Deben C, Boullosa LF, Fortes FR, De La Hoz EC, Le Compte M, Seghers S, Peeters M, Vanlanduit S, Lin A, Dijkstra KK, Van Schil P, Hendriks JMH, Prenen H, Roeyen G, Lardon F, Smits E. Deben C, et al. J Exp Clin Cancer Res. 2024 Mar 22;43(1):88. doi: 10.1186/s13046-024-03012-z. J Exp Clin Cancer Res. 2024. PMID: 38515178 Free PMC article.
"Keep on ROCKIn": Repurposed ROCK inhibitors to boost corneal endothelial regeneration.
Vercammen H, Ondra M, Kotulova J, De La Hoz EC, Witters C, Jecmenova K, Le Compte M, Deben C, Ní Dhubhghaill S, Koppen C, Hajdúch M, Van den Bogerd B. Vercammen H, et al. Among authors: deben c. Biomed Pharmacother. 2024 May;174:116435. doi: 10.1016/j.biopha.2024.116435. Epub 2024 Mar 20. Biomed Pharmacother. 2024. PMID: 38513591 Free article.
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
Van den Eynde A, Gehrcken L, Verhezen T, Lau HW, Hermans C, Lambrechts H, Flieswasser T, Quatannens D, Roex G, Zwaenepoel K, Marcq E, Joye P, Cardenas De La Hoz E, Deben C, Gasparini A, Montay-Gruel P, Le Compte M, Lion E, Lardon F, Van Laere S, Siozopoulou V, Campillo-Davo D, De Waele J, Pauwels P, Jacobs J, Smits E, Van Audenaerde JRM. Van den Eynde A, et al. Among authors: deben c. J Hematol Oncol. 2024 Feb 9;17(1):8. doi: 10.1186/s13045-024-01525-w. J Hematol Oncol. 2024. PMID: 38331849 Free PMC article.
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
Le Compte M, De La Hoz EC, Peeters S, Fortes FR, Hermans C, Domen A, Smits E, Lardon F, Vandamme T, Lin A, Vanlanduit S, Roeyen G, Van Laere S, Prenen H, Peeters M, Deben C. Le Compte M, et al. Among authors: deben c. NPJ Precis Oncol. 2023 Dec 8;7(1):128. doi: 10.1038/s41698-023-00480-y. NPJ Precis Oncol. 2023. PMID: 38066116 Free PMC article.
UAS™-A Urine Preservative for Oncology Applications.
Jordaens S, Arora A, MacDonald KW, Wood C, Hendrickx JO, Zwaenepoel K, Deben C, Tjalma W, Pauwels P, Beyers K, Vankerckhoven V. Jordaens S, et al. Among authors: deben c. Cancers (Basel). 2023 Jun 8;15(12):3119. doi: 10.3390/cancers15123119. Cancers (Basel). 2023. PMID: 37370729 Free PMC article.
Functional Validation of the Putative Oncogenic Activity of PLAU.
Sarno F, Goubert D, Logie E, Rutten MGS, Koncz M, Deben C, Niemarkt AE, Altucci L, Verschure PJ, Kiss A, Berghe WV, Rots MG. Sarno F, et al. Among authors: deben c. Biomedicines. 2022 Dec 30;11(1):102. doi: 10.3390/biomedicines11010102. Biomedicines. 2022. PMID: 36672610 Free PMC article.
41 results